Serving Overlooked PatientsSM

Azurity Pharmaceuticals is a privately held company committed to delivering innovative, high-quality medicines for overlooked patients. Azurity’s global footprint is over 50 countries, with a diversified portfolio of 30+ marketed brands spanning 10 dosage forms and 9 key therapeutic areas. Powered by its Next-Gen Commercial Model, Azurity leverages data, analytics, and AI-driven digital tools to enhance market reach and stakeholder engagement. Our medicines have benefited millions of people.

PRODUCT ANNOUNCEMENT

Azmiro Logo

Learn about AzmiroTM

Click for Full Prescribing Information, including Indications and Safety Information.

PRODUCT ANNOUNCEMENT

Danziten (nilotibin) Logo

Learn about DanzitenTM

Click for Full Prescribing Information, including Indications and Safety Information.

PRODUCT ANNOUNCEMENT

Azmiro Logo

Learn about AzmiroTM

Click for Full Prescribing Information, including Indications and Safety Information.

PRODUCT ANNOUNCEMENT

Danziten (nilotibin) Logo

Learn about DanzitenTM

Click for Full Prescribing Information, including Indications and Safety Information.

OUR PRODUCTS

Azurity offers an ever expanding portfolio of products targeting key therapeutic areas.

News & Events

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma

MEDIA ALERT: WOBURN, MA, March 14, 2025 – Azurity Pharmaceuticals (“Azurity”) announced today the successful completion of its acquisition of Covis Group S.à r.l. (“Covis”) from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity.

read more
Azurity Pharmaceuticals
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.